KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Operating Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -514.00
Dec 31, 2025 -413.00
Sep 30, 2025 -1,176.00
Jun 30, 2025 -850.00
Mar 31, 2025 -2,377.00
Dec 31, 2024 -939.00
Sep 30, 2024 -2,125.00
Jun 30, 2024 -2,529.00
Mar 31, 2024 -3,346.00
Dec 31, 2023 -2,419.00
Sep 30, 2023 -1,288.00
Jun 30, 2023 -1,145.00
Mar 31, 2023 -1,955.00
Dec 31, 2022 44,553.00
Sep 30, 2022 -474.00
Jun 30, 2022 -1,540.00
Mar 31, 2022 -976.00
Dec 31, 2021 -1,023.00
Sep 30, 2021 -1,035.00
Jun 30, 2021 -3,079.00
Mar 31, 2021 -977.00
Dec 31, 2020 -645.00
Sep 30, 2020 -421.00
Jun 30, 2020 -230.00
Mar 31, 2020 -326.00
Dec 31, 2019 663.00
Sep 30, 2019 1,508.00
Jun 30, 2019 961.00
Mar 31, 2019 1,545.00
Dec 31, 2018 1,496.00
Sep 30, 2018 584.00
Jun 30, 2018 1,614.00
Mar 31, 2018 1,628.00
Dec 31, 2017 1,523.00
Sep 30, 2017 1,085.00
Jun 30, 2017 1,057.00
Mar 31, 2017 1,197.00
Dec 31, 2016 1,414.00
Sep 30, 2016 3,227.00
Jun 30, 2016 926.00
Mar 31, 2016 1,011.00
Dec 31, 2015 975.00
Sep 30, 2015 306.00
Jun 30, 2015 -226.00
Mar 31, 2015 -49.00
Dec 31, 2014 -180.00
Sep 30, 2014 -1,272.00
Jun 30, 2014 -166.00
Mar 31, 2014 -948.00